Total planned funding: $421,671,707
Clear active filters
Implementing Agency
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
South Africa | $206,409,201 |
Zambia | $59,651,249 |
Zimbabwe | $21,395,181 |
Tanzania | $19,519,105 |
Ethiopia | $14,727,224 |
Lesotho | $13,789,726 |
Kenya | $13,314,969 |
Mozambique | $12,860,928 |
Uganda | $11,855,846 |
Malawi | $9,473,820 |
Nigeria | $7,042,582 |
Côte d'Ivoire | $5,246,858 |
Ukraine | $4,900,000 |
Guyana | $3,501,915 |
Rwanda | $3,165,000 |
Ghana | $2,995,996 |
Dominican Republic | $2,217,942 |
Namibia | $1,760,882 |
Caribbean Region | $1,745,000 |
Botswana | $1,387,000 |
Haiti | $1,265,000 |
Cameroon | $1,199,851 |
Vietnam | $841,432 |
Indonesia | $650,000 |
Russia | $470,000 |
Cambodia | $285,000 |
Eswatini | $0 |
Organizational Types
Implementing Agency | $421,671,707 |
Program Areas
Treatment | $167,313,869 |
Prevention | $93,695,324 |
Care | $82,354,846 |
Governance and Systems | $43,105,373 |
Testing | $33,704,297 |
Budget Codes
HTXS: Treatment: Adult Treatment | $140,894,666 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $46,492,262 |
HVCT: Testing: HIV Testing and Counseling | $33,704,297 |
HBHC: Care: Adult Care and Support | $33,673,209 |
HVTB: Care: TB/HIV | $23,656,238 |
HVOP: Sexual Prevention: Other Sexual Prevention | $19,705,705 |
OHSS: Health Systems Strengthening | $19,032,535 |
HKID: Care: Orphans and Vulnerable Children | $17,025,258 |
HTXD: Treatment: ARV Drugs | $16,765,648 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $15,563,870 |
HVSI: Strategic Information | $13,918,043 |
HLAB: Laboratory Infrastructure | $10,154,795 |
PDTX: Treatment: Pediatric Treatment | $9,653,555 |
PDCS: Care: Pediatric Care and Support | $8,000,141 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $6,998,693 |
HMBL: Biomedical Prevention: Blood Safety | $3,286,660 |
HMIN: Biomedical Prevention: Injection Safety | $1,278,134 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $370,000 |
Top Partner Programs
TB/HIV Care Association:
$71,558,601
View countries
University of the Witwatersrand:
$65,155,635
View countries